Atlas Trials

Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease

Clinical trial NCT03487263 · COMPLETED

Trial details

NCT number
NCT03487263
Sponsor
Implicit Bioscience
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Motor Neuron DiseaseAmyotrophic Lateral Sclerosis
Start date
2017-10-01
Primary completion
2018-04-18
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.